{"id":"W2069213606","doi":"10.1016/j.ahj.2014.09.007","title":"Transition from apixaban to warfarin—addressing excess stroke, systemic embolism, and major bleeding","year":2014,"lang":"en","type":"editorial","venue":"American Heart Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute; University of British Columbia","funders":"","keywords":"Medicine; Apixaban; Warfarin; Edoxaban; Rivaroxaban; Dabigatran; Atrial fibrillation; Stroke (engine); Vitamin K antagonist; Randomized controlled trial; Clinical trial; Anticoagulant drug; Internal medicine; Anticoagulant; Anesthesia; Intensive care medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008476838,0.003594588,0.005683239,0.003106283,0.002534117,0.006929103,0.003977463,0.01867025,0.007263431],"category_scores_gemma":[0.02956313,0.001315925,0.004089765,0.002081731,0.001848812,0.004101804,0.001327948,0.03260138,0.00416152],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003006359,"about_ca_system_score_gemma":0.005868868,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002810006,"about_ca_topic_score_gemma":0.008412552,"domain_scores_codex":[0.9952829,0.0008637676,0.001064861,0.0005255148,0.001941486,0.0003213192],"domain_scores_gemma":[0.9793036,0.01008973,0.001751439,0.0003301882,0.005889344,0.00263575],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001896047,0.00006864612,0.0001378053,0.0008290646,0.000202243,0.0001638347,0.00002029024,0.00005892813,0.00006487085,0.0003305922,0.97624,0.02169424],"study_design_scores_gemma":[0.001457131,0.0002876323,0.002687874,0.004088772,0.001766113,0.0006239971,0.0001978807,0.0008775022,0.0002982748,0.002277669,0.9853476,0.00008950326],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.0001253703,0.01717905,0.0002037407,0.05391159,0.9271544,0.00004464498,0.000103113,0.00007214613,0.001205978],"genre_scores_gemma":[0.000627043,0.01229116,0.0001837505,0.0282438,0.9563382,0.00004125824,0.00004417364,0.00001536872,0.002215317],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.01867025,"threshold_uncertainty_score":0.04483032,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0438521893147472,"score_gpt":0.3507468568560695,"score_spread":0.3068946675413223,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}